Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
101.00    -0.50 (-0.49%)
Bid:
100.00
Ask:
102.00
Spread: 2.00 (2.00%)
Market Cap: £60.13m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Director/PDMR Shareholding

31 Dec 2020 07:00

RNS Number : 2011K
Crystal Amber Fund Limited
31 December 2020
Ā 

31 December 2020

Ā 

Crystal Amber Fund Limited

(the "Company")

Ā 

Notification of Transactions of Person Discharging Managerial Responsibilities (PDMRs) and Person Closely Associated with Persons Discharging Managerial Responsibilities (PCAs)

The Company has been notified that the Investment Manager, Crystal Amber Asset Management (Guernsey) Limited, a PDMR of the Company has purchased 100,000 ordinary shares in the Company ("Ordinary Shares"). Following the transaction, Crystal Amber Asset Management (Guernsey) Limited holds 7,137,991 Ordinary Shares equivalent to 8.45 per cent. of the Company's voting rights.

Crystal Amber Fund also announces that it has been advised that Juan Morera, an employee of the Investment Adviser to the Company, has sold 50,000 Ordinary Shares.

Details of the transactions can be found in the Notification of Dealing Forms below.

1

Ā 

Details of the person discharging managerial responsibilities / person closely associated

Ā 

a)

Ā 

Name

Ā 

Juan Morera

Ā 

2

Ā 

Reason for the notification

Ā 

a)

Ā 

Position/status

Ā 

Employee of Investment Adviser

Ā 

b)

Ā 

Initial notification /Amendment

Ā 

Initial Notification

3

Ā 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Ā 

a)

Ā 

Name

Ā 

Crystal Amber Fund Limited

b)

Ā 

LEI

Ā 

213800662E2XKP9JD811

Ā 

4

Ā 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Ā 

a)

Ā 

Description of the financial instrument, type of instrument

Ā 

Identification code

Ā 

CRYSTAL AMBER FUND LIMITED, ORDINARY SHARES

Ā 

Ā 

GG00B1Z2SL48

Ā 

b)

Ā 

Nature of the transaction

Ā 

Sale of Ordinary Shares

c)

Ā 

Price(s) and volume(s)

Ā 

Price(s)Ā£0.985

Volume(s)

50,000

d)

Ā 

Aggregated information

- Aggregated volume

- Price

- Principal amount

Ā 

Ā 

50,000

Ā£0.985

Ā£49,250

e)

Ā 

Date of the transaction

Ā 

30 December 2020

f)

Ā 

Place of the transaction

Ā 

London Stock Exchange, AIM Market

Ā 

1

Ā 

Details of the person discharging managerial responsibilities / person closely associated

Ā 

a)

Ā 

Name

Ā 

Crystal Amber Asset Management (Guernsey) Limited

2

Ā 

Reason for the notification

Ā 

a)

Ā 

Position/status

Ā 

Investment Manager

b)

Ā 

Initial notification /Amendment

Ā 

Initial Notification

3

Ā 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Ā 

a)

Ā 

Name

Ā 

Crystal Amber Fund Limited

b)

Ā 

LEI

Ā 

213800662E2XKP9JD811

Ā 

4

Ā 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Ā 

a)

Ā 

Description of the financial instrument, type of instrument

Ā 

Identification code

Ā 

CRYSTAL AMBER FUND LIMITED, ORDINARY SHARES

Ā 

Ā 

GG00B1Z2SL48

Ā 

b)

Ā 

Nature of the transaction

Ā 

Purchase of Ordinary shares

c)

Ā 

Price(s) and volume(s)

Ā 

Price(s)Ā£0.98

Ā£0.985

Volume(s)

50,000

50,000

d)

Ā 

Aggregated information

- Aggregated volume

- Price

- Principal amount

Ā 

Ā 

100,000

Ā£0.9825

Ā£98,250

e)

Ā 

Date of the transactions

Ā 

30 December 2020

f)

Ā 

Place of the transactions

Ā 

50,000 shares - London Stock Exchange, AIM Market

50,000 shares - Off-market

Ā 

Ā 

For further enquiries please contact:Ā 

Ā 

Ā 

Crystal Amber Fund Limited

Ā 

Christopher Waldron (Chairman)

Tel: 01481 742 742

Ā 

Ā 

Allenby Capital Limited - Nominated Adviser

Ā 

David Worlidge/Liz Kirchner

Tel: 020 3328 5656

Ā 

Ā 

Winterflood Investment Trusts - Broker

Ā 

Joe Winkley/Neil Langford

Tel: 020 3100 0160

Ā 

Ā 

Crystal Amber Advisers (UK) LLP - Investment Adviser

Ā 

Richard Bernstein

Tel: 020 7478 9080

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
DSHFLFEDFDLIVII
Date   Source Headline
22nd Dec 20254:48 pmRNSTransaction in Own Shares and Total Voting Rights
19th Dec 20255:04 pmRNSTransaction in Own Shares and Total Voting Rights
19th Dec 20255:04 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20254:57 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20254:57 pmRNSTransaction in Own Shares and Total Voting Rights
17th Dec 20255:57 pmRNSTransaction in Own Shares and Total Voting Rights
17th Dec 20254:15 pmRNSMonthly Net Asset Value
16th Dec 20255:19 pmRNSTransaction in Own Shares and Total Voting Rights
15th Dec 20256:18 pmRNSTransaction in Own Shares and Total Voting Rights
15th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20255:43 pmRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
9th Dec 20255:42 pmRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20255:36 pmRNSTransaction in Own Shares and Total Voting Rights
5th Dec 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
4th Dec 20255:41 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Dec 202510:17 amRNSShare Buyback Programme
2nd Dec 20251:08 pmRNSResult of AGM
1st Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Nov 20256:07 pmRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20256:30 pmRNSTransaction in Own Shares and Total Voting Rights
20th Nov 20257:00 amRNSShare Buyback Programme
20th Nov 20257:00 amRNSMonthly Net Asset Value
18th Nov 20257:00 amRNSDirector/PDMR Shareholding
17th Nov 20256:05 pmRNSTransaction in Own Shares and Total Voting Rights
17th Nov 20255:59 pmRNSHolding(s) in Company
14th Nov 20256:11 pmRNSTransaction in Own Shares and Total Voting Rights
14th Nov 20257:05 amRNSProposed change of strategy and investment manager
13th Nov 20255:39 pmRNSTransaction in Own Shares and Total Voting Rights
6th Nov 20257:00 amRNSNotice of AGM
31st Oct 20255:30 pmRNSTotal Voting Rights
27th Oct 20256:13 pmRNSTransaction in Own Shares and Total Voting Rights
24th Oct 20259:51 amRNSMonthly Net Asset Value
24th Oct 20259:50 amRNSMonthly Net Asset Value
24th Oct 20259:48 amRNSMonthly Net Asset Value
24th Oct 20259:47 amRNSMonthly Net Asset Value
20th Oct 20256:29 pmRNSTransaction in Own Shares and Total Voting Rights
20th Oct 202511:11 amRNSShare Buyback Programme
17th Oct 20257:00 amRNSFinal Results
16th Oct 20257:00 amRNS-RInvestor Presentation by Morphic Medical Inc
7th Oct 20257:00 amRNS-RInvestor Presentation by Morphic Medical Inc
30th Sep 20255:00 pmRNSTransaction in Own Shares and Total Voting Rights
29th Sep 20255:04 pmRNSTransaction in Own Shares and Total Voting Rights
25th Sep 20255:26 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Sep 20257:00 amRNS-RMorphic Medical Inc. appoints new CFO
10th Sep 20255:21 pmRNSTransaction in Own Shares and Total Voting Rights
4th Sep 20255:29 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Sep 20255:31 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.